Members of Rx&D share the mission to improve the health of Canadians through the discovery, development, manufacturing and distribution of innovative prescription medicines. Implicit in this mission are commitments to undertake and promote research, to ensure healthcare providers and patients receive the education and information to use members' products and services appropriately, and for members to observe their social responsibilities and role to improve the health and social environments that Canadians enjoy.
Underlining our commitment to the health of Canadians is our assurance for ethical practices. Rx&D members adhere to a strict Code of Ethical Practices that governs all interaction with healthcare professionals in Canada and is a key program of industry self-regulation. Rx&D’s Code of Ethical Practices is constantly evolving in a manner that reflects the realities of the changing environment for the pharmaceutical industry in Canada.
In recognition of its role in the international pharmaceutical community, Rx&D is a member of the International Federation of Pharmaceutical Manufacturers Associations (IFPMA). The IFPMA is a non-governmental organization representing pharmaceutical associations in 51 countries around the world.
As a member of the IFPMA, Rx&D strongly supports IFPMA's mission and the principles of its Code of Pharmaceutical Marketing Practices. We urge our member companies to publicly affirm their corporate commitment to honour the principles and ideals that IFPMA has set for our industry.